SCHEMBL8539736

SCHEMBL8539736

O=C(O)CN1CCN(CC(=O)O)CCN(CC(O)COc2ccc(Cl)cc2)CCN(CC(=O)O)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.70
CACNA1G O43497 3/20 0.70
KMT2A Q03164 1/20 0.66
LMNA P02545 2/20 0.63
MAPK1 P28482 1/20 0.63
RECQL P46063 1/20 0.63
HTR7 P34969 1/20 0.63
MAPT P10636 3/20 0.61
L3MBTL1 Q9Y468 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
DRD4 P21917 1/20 0.59
KDM4E B2RXH2 1/20 0.58
GLA P06280 1/20 0.58
USP2 O75604 1/20 0.58
TSHR P16473 1/20 0.58
ATM Q13315 1/20 0.57
ALDH1A1 P00352 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11365346 0.89 KCNH2 (0.86) KCNH2CACNA1GKMT2ALMNAMAPK1
SCHEMBL8541852 0.88 MAPT (0.61) MAPK1HTR7MAPTL3MBTL1SMN1; SMN2
SCHEMBL8482810 0.88 L3MBTL1 (0.78) KMT2AMAPK1HTR7MAPTL3MBTL1
SCHEMBL7882866 0.87 MAPT (0.67) MAPK1HTR7MAPTL3MBTL1SMN1; SMN2
SCHEMBL7159605 0.87 MAPT (0.60) MAPK1HTR7MAPTL3MBTL1SMN1; SMN2
SCHEMBL8541877 0.87 KDM4E (0.69) KMT2AMAPK1MAPTL3MBTL1DRD4
SCHEMBL8541479 0.86 MAPT (0.59) KCNH2CACNA1GMAPK1MAPTL3MBTL1
SCHEMBL7281725 0.84 KCNH2 (0.69) KCNH2CACNA1GKMT2ALMNAMAPK1
SCHEMBL8541454 0.84 ABCB1 (0.59) KCNH2CACNA1GKMT2AHTR7MAPT
SCHEMBL11370338 0.83 KCNH2 (0.68) KCNH2CACNA1GKMT2ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485045-B1 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AG (DE) 1998-12-30 EP disclosed
US-5277895-A Nuclear magnetic resonance SCHERING AKTIENGESELLSCHAFT (DE) 1994-01-11 US disclosed
EP-0485045-A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-13 EP disclosed